Taiyo Holdings has appointed Hitoshi Saito as chairman of the board, effective June 20, while he remains the company's representative director, president and group CEO. The decision was taken at a June 20 board meeting.
The practical change is a concentration of roles, not a handover to a new figure. In a separate same-day notice on directors' duties, Taiyo said Saito will also continue to oversee risk management and the research division.
For investors, that means the board chair now sits with the executive already responsible for leading the group. Taiyo's disclosures here do not set out a reason for the change, and the provided materials do not identify the previous chair.
The companion duties notice also shows Taiyo keeping separate leaders for its electronics business and its medical and pharmaceutical business, rather than folding every operating brief into the top job. Even so, the board leadership role itself now sits with Saito's executive seat.
The chairmanship is also going to a long-serving internal executive. The filing's career summary lists earlier management roles for Saito across the group's overseas operations, including posts in Singapore and Thailand, before his rise to president and group CEO.